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Introduction   
   
The tobacco plant belongs to the family Solanaceae. Its biological name is Nicotiana 
tabacum . It is a perennial herbaceous plant that grows to a height of 2-3 meters. Its 
leaves are commercially grown and processed into tobacco in various different forms 
like bidi, cigars, cigarettes, hookah, pipe smoking, snuff, gutkha, mawa, khaini etc. The 
usage of these different forms of tobacco is an activity that is generally practiced by 
about1/3
rd
 of the adult population around the world. The World Health Organization 
(WHO) reports it to be the leading cause of death worldwide and estimates that it 
currently causes 5.4 million deaths per year(2).
 
       The tobacco plant usually gets infected by a virus known as Tobacco mosaic virus 
(TMV). TMV is an RNA virus that causes a characteristic pattern on the leaves which is 
mottling and discoloration, and hence the name. It is a thermostable virus that can 
withstand upto 120° F or 50° C for 30 minutes on dried leaves. It has no effect on 
humans and animals. The plant infected with this virus offers an advantage of 
generating antibodies against Non Hodgkin’s lymphoma in a very short period of 
time. The tobacco plant thus acts as a double edged sword which can cause cancer as 
well as treat cancer. 
        Non Hodgkin’s lymphomas are a heterogenous group of lymphoproliferative 
malignancies which can involve lymph nodes, lymphoid organs as well as extranodal 
organs and tissues(3). Non-Hodgkin’s lymphomas represent the sixth most common 
cancer in the United States as well as the sixth most common cause of cancer 
deaths(4). These include a broad range of neoplasms derived from the T cells and B 
cells and their precursors in the lymphoid system. Although they are not among the 
most common cancers, the lymphomas have attracted a great deal of interest among 
researchers. This is because of their interesting biology and varied responsiveness to 
therapy.
 
About 80% of cases originate from B lymphocyte series. Tumors with a T 
lymphocyte derivation are less common(5,6).
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Abstract      
                         
The tobacco plant is the cause for millions of cancer cases worldwide. This plant now offers 
physicians a way to rapidly make vaccines that are able to fight cancer like Non Hodgkin’s 
lymphoma by upregulating the patient’s own immune mechanism to fight cancer. The 
Tobacco plant is a member of Solanaceae family and usually gets infected by a virus known as 
Tobacco Mosaic Virus (TMV).Viral replication occurs very rapidly in this plant and hence when 
the gene extracted from the patient’s malignant cell is infused into the tobacco leaves which 
are infected by this virus, it generates the production of cell- surface antigen within a very 
short span. This antigen after purification is then injected into the same patient evoking the 
production of tailor-made antibodies and thus upregulating the patient’s immune system. The 
aim of this therapy is to build up one’s own immune system to fight against his/her own 
cancer. This short article highlights the method by which the tobacco plant could thus act as a 
double edged sword.
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most common cancers, the lymphomas have attracted a 
great deal of interest among researchers. This is because 
of their interesting biology and varied responsiveness to 
therapy.
 
About 80% of cases originate from B 
lymphocyte series. Tumors with a T lymphocyte 
derivation are less common(5,6).
  
             
In this cancer, a single antibody-producing B 
lymphocyte breaks free from normal growth controls 
and multiplies uncontrollably, producing many identical 
clones of itself. This form of cancer is unique because the 
malignant B cells in each patient carry a distinctive 
marker on their surface which is not normally found on 
the body’s healthy cells(1,3,4).
 
Hence by generating 
antibodies against this surface marker, one can stimulate 
the immune system and attack the lymphoma cells. 
 
         Researchers were able to produce these antibodies 
by using bacteria but they were found to be insoluble 
and hence were ineffective. Later, animal studies were 
carried out but they were very time consuming. It was at 
this point that the use of tobacco plant as an alternative 
method for protein production was developed,
 
that 
could generate antibodies customized for each patient. 
These antibodies recognize the cell surface marker and 
target the malignant cells resulting in their 
destruction(4,7).
 
        Thus a unique tailor-made vaccine can be produced 
for every patient to fight his/her own cancer.  
 
PROCEDURE 
TUMOR CELL SAMPLE TAKEN FROM PATIENT OF NON 
HOGKIN’S LYMPHOMA 
 
GENE EXTRACTED FROM THE TUMOR CELLS CODED 
WITH CELL SURFACE ANTIGEN
7
 
 
GENE INSERTED INTO TOBACCO MOSAIC VIRUS BY 
GENTLY SCRAPING THE LEAVES 
 
VIRUS SPREAD THROUGHOUT THE LEAVES WITHIN ONE 
WEEK 
 
ANTIGEN EXTRACTED FROM THE LEAVES BY 
PURIFICATION AND CHROMATOGRAPHY METHODS
8,9,10
 
 
ANTIGEN INJECTED INTO THE SAME PATIENT 
ANTIBODIES FOR SPECIFIC CELL SURFACE ANTIGENS 
PRODUCED 
 
IMMUNE SYSTEM OF 70% PATIENT PERKED UP 
 
ADVANTAGES  
   The advantages of this plant vaccine is that it is 
cheaper and carry minimal risk to the patient, as against 
the animal-grown vaccines.This procedure has no side 
effects and results in developing antibodies within 2-3 
weeks. Hence personalized cancer vaccine for individual 
patient can be produced very effectively. 
 
 OTHER APPLICATIONS 
Some other applications of tobacco plant in the field of 
plant technology include :- 
1.  The genetically modified tobacco plants are used to 
produce interleukin 10 to treat patient with type 1 
diabetes(11) .  
  2. The Tobacco plant is also used to develop antibodies 
against HIV. EU Pharma Plant project -Germany’s 
Fraunhofer, established the fundamental principles 
required to produce the HIV –neutralis 2G12 in these 
plants(12).
 
3.  This plant is also used to produce vaccine for 
Norovirus infection which causes diahorrea and 
vomiting(13).  
 
  4. The tobacco plant is coated with 30 nanometer long 
chunks of platinum nanoparticles in order to create a fast 
switching transistor. These transistors could be 
manufactured into memory chips to replace 
conventional flash memory in electronic devices(14). 
 
 
CONCLUSION 
         This is a short article which highlights the 
benevolent role of the tobacco plant as an angel who is 
used to cure cancer by production of customized, tailor 
made, specific antibodies and eliciting the immune 
system to fight against the patient’s own cancer. 
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